|Disease Group:||Advanced Cancers|
|Phase of Study:||Phase I|
|Treatment Location:||Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions|
|Estimated Length of Stay in Houston:||N/A|
|Return Visit:||Weekly during cycle 1, at the end of cycle 2, and after second cycle every 1-2 |
cycles usually before the next cycle.
|Home Care:|| Patients will be able to self-administer Sirolimus at home. The initial or |
loading doses of Cetuximab will be given in the clinic. Subsequent doses may
be given at home.